Sale!

GJB6 Gene Deafness Autosomal Dominant Type 3B Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “GJB6 Gene Deafness Autosomal Dominant Type 3B Genetic Test” is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the GJB6 gene, which are associated with Autosomal Dominant Deafness Type 3B (DFNA3B). This condition is a form of genetic hearing loss where the affected individual inherits the mutated gene from one parent, leading to varying degrees of hearing impairment that can present at any age.

The GJB6 gene plays a crucial role in the function of cochlear hair cells and the maintenance of potassium levels in the inner ear, which are essential for normal hearing. Mutations in this gene disrupt these processes, leading to hearing loss.

The test is conducted using a sample of the patient’s DNA, typically extracted from a blood sample or cheek swab. The genetic material is then analyzed using advanced molecular techniques to identify any mutations in the GJB6 gene.

Priced at 4400 AED, this test is a critical tool for individuals with a family history of hearing loss, offering them valuable insights into their genetic predisposition. Early detection through this test can facilitate timely interventions and management strategies, improving the quality of life for those affected. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing outcomes for patients seeking clarity on their genetic health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GJB6 Gene Deafness autosomal dominant type 3B Genetic Test

At DNA Labs UAE, we offer the GJB6 Gene Deafness autosomal dominant type 3B Genetic Test at a cost of AED 4400.0.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Before undergoing the GJB6 Gene Deafness autosomal dominant type 3B Genetic Test, it is important to provide the clinical history of the patient. This includes any symptoms or conditions related to IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by the gene IARS5.

Test Details

The GJB6 gene is associated with a type of deafness known as autosomal dominant type 3B (DFNA3B). This genetic condition causes progressive hearing loss that usually begins in childhood or adolescence. The NGS (Next-Generation Sequencing) technology allows for the simultaneous analysis of multiple genes or even the entire exome in a person’s DNA. In the case of GJB6 gene deafness, the NGS genetic test involves sequencing the GJB6 gene to identify any mutations or variations that may be responsible for the individual’s hearing loss.

By identifying specific mutations in the GJB6 gene, the NGS testing can provide a definitive diagnosis for individuals with autosomal dominant type 3B deafness. This information is valuable for understanding the underlying cause of the hearing loss, predicting disease progression, and potentially guiding treatment options or interventions.

Test Name GJB6 Gene Deafness autosomal dominant type 3B Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS5
Test Details

The GJB6 gene is associated with a type of deafness known as autosomal dominant type 3B (DFNA3B). This genetic condition causes progressive hearing loss that typically starts in childhood or adolescence.

NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous analysis of multiple genes or even the entire exome (all protein-coding genes) in a person’s DNA. In the context of GJB6 gene deafness, an NGS genetic test would involve sequencing the GJB6 gene to identify any mutations or variations that may be responsible for the individual’s hearing loss.

By identifying specific mutations in the GJB6 gene, NGS testing can provide a definitive diagnosis for individuals with autosomal dominant type 3B deafness. This information can be valuable for understanding the underlying cause of the hearing loss, predicting disease progression, and potentially guiding treatment options or interventions.